VALIDATION STUDY

The Pediatric Asthma Impairment and Risk Questionnaire (Peds-AIRQ®) is a validated composite control tool designed to identify the level of asthma control for children 5 to 11 years of age.

Asthma Impairment and Risk
Asthma Impairment and Risk

A VALIDATED PEDS-AIRQ® DESIGN1

Validated Pediatrics AIRQ
Validated Pediatrics AIRQ

A VALIDATED PEDS-AIRQ® DESIGN1

Peds-AIRQ® is a 8-item, equally weighted, yes/no composite asthma control questionnaire.

It combines 5 impairment and 3 risk items that address a broad array of factors that are relevant to children with asthma of all disease severities:

  • Daytime and nighttime symptoms
  • Rescue medication use
  • Participation in planned activities
  • Physical activity
  • Exacerbations
  • Related health care resource utilization, including emergency room or in-patient hospital care

The Peds-AIRQ®'s simple response format provides critical information necessary for assessing asthma control.

PEDS-AIRQ® VS EXISTING MEASURES OF ASTHMA CONTROL1

Measures Of Pediatrics Asthma Control
Measures Of Pediatrics Asthma Control

PEDS-AIRQ® VS EXISTING MEASURES OF ASTHMA CONTROL1

A number of validated asthma control measures for children 5 to 11 years with asthma, like the Peds-AIRQ®, are in existence today.

However, some of the measures being used in clinical practice are limited by assessing only the impairment domain of control. Furthermore, asthma control is often overestimated by providers and patients.

Among the 259 children participating in the cross-sectional Peds-AIRQ® validation study who were rated by physicians as completely or well-controlled, 32% experienced at least 1 exacerbation in the prior year.

To address the limitations of existing measures, the Peds-AIRQ® design was informed by a large and diverse team of scientists and clinicians with expertise and experience in asthma management., representing the providers who will ultimately use the tool with their patients. Learn more about the team who created the Peds-AIRQ® here.

SENSITIVITY & SPECIFICITY1

Diagnosed Asthma
Diagnosed Asthma

SENSITIVITY & SPECIFICITY1

Peds-AIRQ® was validated in a study comprised of 399 children aged 5 to 11 years with physician-diagnosed asthma.

Patients spanned all disease severities and were classified as well-controlled, not well-controlled, or very poorly controlled according to a standard of GINA symptom control tool score plus prior-year, chart-documented exacerbations.

The combination of selected Pediatric AIRQ® items and cut points of control demonstrated a sensitivity of 0.79 to identify children whose asthma was well-controlled (cut point of ≥2 yes responses), and a specificity of 0.95 to determine children whose asthma was very poorly controlled (cut point of ≥5 yes responses).

For further information on the development and cross-sectional validation of the Peds-AIRQ®, please refer to Murphy KR, et al. J Allergy Clin Immunol Pract. 2025. doi: 10.1016/j.jaip.2025.06.039

If you want to use Peds-AIRQ® in your research, click here for information on licensing Peds-AIRQ®.

Interested in using the Peds-AIRQ® in your practice?
Experience how Peds-AIRQ® is completed by your patients and parents or caregivers.

Murphy KR, Chipps B, Lanz MJ, et al. Pediatric Asthma Impairment and Risk Questionnaire: A Control Assessment for Children Aged 5-11 Years. J Allergy Clin Immunol Pract. 2025. doi: 10.1016/j.jaip.2025.06.039.